Michael Palmer
Impact in
- Cancer Research top 1%
- Breast Cancer Treatment Studies
- Oncology top 1%
- HER2/EGFR in Cancer Research
- Cancer survivorship and care
- Bone health and treatments
Papers in
-
- Lung Cancer Treatments and Mutations 10
- Co-authors
- Joseph L. Pater (20 shared papers)Dongsheng Tu (17 shared papers)Lois E. Shepherd (13 shared papers)James N. Ingle (11 shared papers)Kathleen I. Pritchard (12 shared papers)Silvana Martino (12 shared papers)Nicholas J. Robert (12 shared papers)Edith A. Perez (9 shared papers)
- Journals
- Journal of Clinical Oncology (15 papers)Journal of Medicinal Chemistry (7 papers)Annals of Oncology (5 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)Quality of Life Research (4 papers)
- Partner nations
- United KingdomCanadaUnited States
In The Last Decade
Michael Palmer
99 papers receiving 4.6k citations
Michael Palmer's Hit Papers
Peers
Comparison fields: 5 of 152
- Cancer Research 1.1k
- Oncology 1.6k
- Genetics 1.2k
- Pulmonary and Respiratory Medicine 907
- Family Practice 29
Countries citing papers authored by Michael Palmer
This map shows the geographic impact of Michael Palmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Palmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Palmer more than expected).
Fields of papers citing papers by Michael Palmer
This network shows the impact of papers produced by Michael Palmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Palmer. The network helps show where Michael Palmer may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Palmer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17 Hit paper breakdown → | 2005 | 824 |
| 2 | 2004 | 250 | |
| 3 | 2013 | 246 | |
| 4 | 2006 | 234 | |
| 5 | 2005 | 194 | |
| 6 | 2005 | 146 | |
| 7 | 1988 | 145 | |
| 8 | 2008 | 136 | |
| 9 | 2008 | 131 | |
| 10 | 2002 | 117 | |
| 11 | 1987 | 103 | |
| 12 | 2008 | 98 | |
| 13 | 2007 | 95 | |
| 14 | 1994 | 92 | |
| 15 | 2016 | 90 | |
| 16 | 1997 | 84 | |
| 17 | 2010 | 77 | |
| 18 | 2014 | 74 | |
| 19 | 2006 | 66 | |
| 20 | 1997 | 64 |
About Michael Palmer
Michael Palmer is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Organic Chemistry and Political Science and International Relations, having authored 105 papers that have together received 4.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (10 papers), Nausea and vomiting management (7 papers), Breast Cancer Treatment Studies (6 papers), Estrogen and related hormone effects (6 papers), Helminth infection and control (6 papers), Conflict of Laws and Jurisdiction (6 papers), Cancer survivorship and care (5 papers) and Cancer Treatment and Pharmacology (5 papers). The work is most often cited by research in Cancer Research (1.1k citations), Oncology (1.6k citations), Genetics (1.2k citations), Pulmonary and Respiratory Medicine (907 citations) and Family Practice (29 citations). Michael Palmer has collaborated with scholars based in United Kingdom, Canada and United States. Frequent co-authors include Joseph L. Pater, Dongsheng Tu, Lois E. Shepherd, James N. Ingle, Kathleen I. Pritchard, Silvana Martino, Nicholas J. Robert, Edith A. Perez, Hyman B. Muss and Martine Piccart. Their work appears in journals such as Journal of Clinical Oncology, Journal of Medicinal Chemistry, Annals of Oncology, Bioorganic & Medicinal Chemistry Letters and Quality of Life Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.